Positions

Assistant Professor
Otolaryngology-Head & Neck Surgery
Baylor College of Medicine
Houston, TX, US
Member
Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, Texas, United States

Education

MD-PhD from University of Pittsburgh School of Medicine
Residency at Baylor College of Medicine, Department of Otolaryngology Head and Neck Surgery
Clinical Fellowship at University of Texas MD Anderson Cancer Center, Department of Head and Neck Surgery

Certifications

Diplomate
American Board of Otolaryngology-Head and Neck Surgery

Professional Interests

  • Thyroid cancer
  • Laryngeal and pharyngeal cancer
  • Salivary gland neoplasm
  • Melanoma
  • Advanced skin cancer

Professional Statement

Vlad C. Sandulache MD, PhD is a board certified otolaryngologist specializing in Head and Neck Surgical Oncology. Dr. Sandulache earned his MD and PhD from the University of Pittsburgh, and completed his residency in Otolaryngology Head and Neck Surgery at Baylor College of Medicine. Following residency, Dr. Sandulache completed a clinical fellowship in the Department of Head and Neck Surgery at The University of Texas MD Anderson Cancer Center where he received advanced training in minimally invasive surgical techniques for pharyngeal and laryngeal malignancies including transoral robotic surgery (TORS) and transoral laser surgery.

Dr. Sandulache utilizes a multidisciplinary approach to the management of patients with head and neck cancer with active participation in both surgical and non-surgical clinical trials. His primary clinical expertise is in the management of early and advanced stage oropharyngeal and laryngeal cancer, salivary gland neoplasms and poorly differentiated and anaplastic thyroid carcinoma.

Dr. Sandulache maintains an active basic science and clinical research program focused on elucidating the link between cancer metabolism and treatment effectiveness. The goal of this research program is to develop personalized treatment strategies based on tumor genomic information and metabolic response to conventional and targeted treatment strategies. One application of this approach currently underway is development of more effective treatments for poorly differentiated and anaplastic thyroid carcinoma.

Selected Publications

Memberships

American Head and Neck Society